Man Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $91.9M | Sell |
1,147,468
-462,568
| -29% | -$38.1M | 0.17% | 138 |
|
|
2025
Q4 | $137M | Sell |
1,610,036
-357,397
| -18% | -$29.3M | 0.23% | 96 |
|
|
2025
Q3 | $153M | Buy |
1,967,433
+313,494
| +19% | +$24.5M | 0.27% | 80 |
|
|
2025
Q2 | $129M | Buy |
1,653,939
+702,712
| +74% | +$52.4M | 0.25% | 87 |
|
|
2025
Q1 | $68.9M | Buy |
951,227
+391,777
| +70% | +$28M | 0.17% | 129 |
|
|
2024
Q4 | $41.4M | Buy |
559,450
+116,528
| +26% | +$8.16M | 0.11% | 220 |
|
|
2024
Q3 | $29.2M | Sell |
442,922
-409,188
| -48% | -$29.7M | 0.08% | 323 |
|
|
2024
Q2 | $78.7M | Buy |
852,110
+401,966
| +89% | +$35.6M | 0.2% | 113 |
|
|
2024
Q1 | $43M | Buy |
450,144
+106,820
| +31% | +$8.97M | 0.11% | 204 |
|
|
2023
Q4 | $26.2M | Buy |
+343,324
| New | +$23.9M | 0.07% | 315 |
|
|
2023
Q3 | – | Sell |
-531,868
| Closed | -$42.7M | – | 61 |
|
|
2023
Q2 | $50.2M | Buy |
+531,868
| New | +$46.2M | 0.15% | 141 |
|
|
2023
Q1 | – | Sell |
-1,070,715
| Closed | -$84.2M | – | 122 |
|
|
2022
Q4 | $79.9M | Buy |
1,070,715
+232,636
| +28% | +$17.9M | 0.29% | 68 |
|
|
2022
Q3 | $69.3M | Buy |
+838,079
| New | +$80.6M | 0.32% | 55 |
|
|
2022
Q2 | – | Sell |
-814,136
| Closed | -$84.3M | – | 39 |
|
|
2022
Q1 | $95.8M | Sell |
814,136
-58,869
| -7% | -$6.6M | 0.33% | 55 |
|
|
2021
Q4 | $113M | Sell |
873,005
-346,894
| -28% | -$40.5M | 0.36% | 52 |
|
|
2021
Q3 | $138M | Sell |
1,219,899
-43,295
| -3% | -$4.94M | 0.48% | 32 |
|
|
2021
Q2 | $131M | Buy |
1,263,194
+829,870
| +192% | +$78.2M | 0.46% | 32 |
|
|
2021
Q1 | $36.2M | Sell |
433,324
-50,139
| -10% | -$4.24M | 0.16% | 135 |
|
|
2020
Q4 | $44.1M | Sell |
483,463
-324,379
| -40% | -$26.9M | 0.19% | 103 |
|
|
2020
Q3 | $64.5M | Sell |
807,842
-73,929
| -8% | -$5.77M | 0.25% | 87 |
|
|
2020
Q2 | $60.9M | Buy |
881,771
+310,655
| +54% | +$22.1M | 0.31% | 64 |
|
|
2020
Q1 | $35.9M | Sell |
571,116
-85,086
| -13% | -$6.14M | 0.23% | 92 |
|
|
2019
Q4 | $51M | Buy |
656,202
+555,831
| +554% | +$43.4M | 0.17% | 127 |
|
|
2019
Q3 | $7.36M | Sell |
100,371
-40,134
| -29% | -$2.82M | 0.03% | 702 |
|
|
2019
Q2 | $8.65M | Sell |
140,505
-56,211
| -29% | -$3.4M | 0.03% | 696 |
|
|
2019
Q1 | $12.5M | Buy |
196,716
+2,148
| +1% | +$123K | 0.05% | 482 |
|
|
2018
Q4 | $9.93M | Sell |
194,568
-324,414
| -63% | -$16.4M | 0.04% | 455 |
|
|
2018
Q3 | $30.1M | Buy |
518,982
+204,069
| +65% | +$9.98M | 0.11% | 196 |
|
|
2018
Q2 | $15.3M | Buy |
314,913
+32,274
| +11% | +$1.51M | 0.06% | 370 |
|
|
2018
Q1 | $13.1M | Buy |
+282,639
| New | +$12.3M | 0.06% | 367 |
|
Other funds holding EW
VCM
VPM
Man Group's EW Position: Q1 2026 in Review
Man Group reduced its Edwards Lifesciences (EW) stake by 29% in Q1 2026, selling an estimated $38.1M and leaving 1,147,468 shares worth $91.9M. The position accounts for 0.17% of the portfolio, ranked #138.
Man Group first reported a position in EW in Q1 2018 and has held it in 30 quarters since. The position peaked at $153M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Man Group held 1,147,468 shares of Edwards Lifesciences worth $91.9M as of Q1 2026.
- Man Group sold 462,568 Edwards Lifesciences shares in Q1 2026, an estimated $38.1M.
- Edwards Lifesciences made up 0.17% of Man Group's portfolio in Q1 2026, its #138 holding.
- Man Group first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 30 quarters since.
- Man Group's Edwards Lifesciences position peaked at $153M in Q3 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.